Posted by Michael Wonder on 08 Jun 2026
ICER publishes final evidence report on treatment for narcolepsy
8 June 2026 - The ICER today released a final evidence report assessing the comparative clinical effectiveness and value of oveporexton (Takeda) for narcolepsy type 1.
ICER’s report on this therapy was the subject of the May 2026 public meeting of the Midwest CEPAC, one of ICER’s three independent evidence appraisal committees.
